Cargando…
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN(®), induces robust humoral and cellular immunity in mice and non-human primates
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers a flexible and scalable platform to address the urgent need for world-wide immunization in pandemic situations. This strategic powerful platform has recently been used to immunize millions of people proving bo...
Ejemplares similares
-
Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development
por: Ansariniya, Hossein, et al.
Publicado: (2021) -
Response of creatine kinase and lactate dehydrogenase enzymes to rest interval between sets and set-repetition configuration during bouts of eccentric exercise
por: Mohammadi, Hossein, et al.
Publicado: (2018) -
Adrenal hematoma following falling in a 5-year-old boy
por: Guitynavard, Fateme, et al.
Publicado: (2020) -
Effectiveness of zinc chloride mouthwashes on oral mucositis and weight of patients with cancer undergoing chemotherapy
por: Oshvandi, Khodayar, et al.
Publicado: (2021) -
Comparison of Osteoblastic Differentiation of Human Periodontal Ligament Stem
Cells through Application of Two β-tricalcium Phosphate Products: An in vitro Study
por: Mirkhani, Seyed Mohammad Hossein, et al.
Publicado: (2022)